1,401
Views
4
CrossRef citations to date
0
Altmetric
HPV – Research Article

Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination

, , , , , , & ORCID Icon show all
Article: 2132755 | Received 08 Jul 2022, Accepted 27 Sep 2022, Published online: 20 Oct 2022

References

  • Meites E, Gee J, Unger E, Markowitz, L. Human papillomavirus. In: Hamborsky J, editor. Epidemiology and prevention of vaccine-preventable diseases. 13th ed.; 2015. p. 1–8. https://www.cdc.gov/vaccines/pubs/pinkbook/hpv.html#hpv
  • Centers for Disease Control and Prevention. Genital HPV infection - fact sheet; 2022 Jan 3 [assessed 2022 Feb 14]. https://www.cdc.gov/std/hpv/stdfact-hpv.htm
  • Chesson HW, Ekwueme DU, Saraiya M, Watson M, Lowy DR, Markowitz LE. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine. 2012;30(42):6016–19. doi:10.1016/j.vaccine.2012.07.056.
  • De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. International Journal of Cancer. 2017;141(4):664–70. doi:10.1002/ijc.30716.
  • CPRIT. An economic assessment of the cost of cancer in Texas and the benefits of the cancer prevention and research institute of Texas (CPRIT) and its programs: 2020 update; 2020 [accessed 2021 Nov 29]. https://www.cprit.state.tx.us/media/2456/perryman_cprit_impact_2020-01212021.pdf
  • Centers for Disease Control and Prevention. Human papillomavirus: cancers caused by HPV are preventable; 2021 [accessed 2021 Nov 29]. https://www.cdc.gov/hpv/hcp/protecting-patients.html
  • Centers for Disease Control and Prevention. Standards for adult immunization practice; 2016 [accessed 2021 Nov 29]. https://www.cdc.gov/vaccines/hcp/adults/for-practice/standards/index.html
  • Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68(32):698–702. doi:10.15585/mmwr.mm6832a3.
  • Pingali C, Yankey D, Elam-Evans LD, Markowitz LE, Williams CL, Fredua B, McNamara LA, Stokley S, Singleton JA. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2020. Morbidity and Mortality Weekly Report. 2021;70(35):1183–90. doi:10.15585/mmwr.mm7035a1.
  • World Health Organization. Accelerating the elimination of cervical cancer as a global public health problem. executive board, 146th session, provisional agenda item 9 (EB146/9); 2019 [accessed 2021 Nov 29]. https://apps.who.int/gb/ebwha/pdf_files/EB146/B146_9-en.pdf
  • Office of Disease Prevention and Health Promotion. HPV immunization. Healthy people 2030. U.S. Department of Health and Human Services; n.d. [accessed 2021 Nov 29]. https://health.gov/healthypeople/search?query=HPV+immunization
  • Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician’s recommendation. Vaccine. 2009;29(5):890–95. doi:10.1016/j.vaccine.2009.12.063.
  • Oh NL, Biddell CB, Rhodes BE, Brewer NT. Provider communication and HPV vaccine uptake: a meta-analysis and systematic review. Prev Med. 2021;148:106554. doi:10.1016/j.ypmed.2021.106554.
  • Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 2016;34(9):1187–92. doi:10.1016/j.vaccine.2016.01.023.
  • Kulczycki A, Qu H, Shewchuk R. Primary care physicians’ adherence to guidelines and their likelihood to prescribe HPV vaccine for 11-12 year-old girls. Women’s Health Issues. 2015;26(1):34–39. doi:10.1016/j.whi.2015.07.012.
  • Brewer NT, Mitchell CG, Alton Dailey S, Hora L, Fisher-Borne M, Tichy K, McCoy T. HPV vaccine communication training in healthcare systems: evaluating a train-the-trainer model. Vaccine. 2021;39(28):3731–36. doi:10.1016/j.vaccine.2021.05.038.
  • Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2013;168(1):76–82. doi:10.1001/jamapediatrics.2013.2752.
  • Eisenhauer L, Hansen BR, Pandian V. HPV immunization among young adults (HIYA!) in family practice: a quality improvement project. J Adv Nurs. 2021;78(5):1366–76. doi:10.1111/jan.15090.
  • Leung SOA, Akinwunmi B, Elias KM, Feldman S. Educating healthcare providers to increase human papillomavirus (HPV) vaccination rates: a qualitative systematic review. Vaccine: X. 2019;3:100037. doi:10.1016/j.jvacx.2019.100037.
  • Kasting ML, Wilson S, Dixon BE, Downs SM, Kulkarni A, Zimet GD. A qualitative study of healthcare provider awareness and informational needs regarding the nine-valent HPV vaccine. Vaccine. 2016;34(11):1331–34. doi:10.1016/j.vaccine.2016.01.050.
  • LexisNexis. Master provider referential database; 2022 [accessed 2022 Mar 10]. https://risk.lexisnexis.com/
  • Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;370(9596):1453–57. doi:10.1016/S0140-6736(07)61602-X.
  • U.S. Department of Agriculture. Rural-urban continuum codes; 2020. https://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx
  • StataCorp. Stata statistical software: release 15. College Station, TX: Stata Corp LLC; 2017.
  • Centers for Disease Prevention and Control. Vaccines and preventable diseases: resources, education & references for HPV vaccination; 2021 [accessed 2021 Nov 29]. https://www.cdc.gov/vaccines/vpd/hpv/hcp/resources.html
  • Kasting ML, Scherr CL, Ali KN, Lake P, Malo TL, Johns T, Roetzheim RG, Quinn GP, Vadaparampil ST. Human papillomavirus vaccination training experience among family medicine residents and faculty. Fam Med. 2017;49:714–22.
  • Dempsey AF, Pyrznawoski J, Lockhart S, Barnard J, Campagna EJ, Garrett K, Fisher A, Dickinson LM, O’Leary ST. Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial. JAMA Pediatr. 2018;172(5):e180016. doi:10.1001/jamapediatrics.2018.0016.
  • Vu M, King AR, Jang HM, Bednarczyk RA. Practice-, provider- and patient-level facilitators of and barriers to HPV vaccine promotion and uptake in Georgia: a qualitative study of healthcare providers’ perspectives. Health Educ Res. 2020;35(6):512–23. doi:10.1093/her/cyaa026.
  • Rand CM, Schaffer SJ, Dhepyasuwan N, Blumkin A, Albertin C, Serwint JR, Darden PM, Humiston SG, Mann KJ, Stratbucker W, et al. Provider communication, prompts, and feedback to improve HPV vaccination rates in resident clinics. Pediatrics (Evanston). 2018;141(4):e20170498. doi:10.1542/peds.2017-0498.
  • Berenson AB, Laz TH, Hirth JM, McGrath CJ, Rahman M. Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age. Human Vaccines & Immunotherapeutics. 2014;10(7):1807–11. doi:10.4161/hv.28779.
  • Emmers-Sommer TM, Nebel S, Allison M, Cannella ML, Cartmill D, Ewing S, Horvath D, Osborne JK, Wojtaszek B. Patient–provider communication about sexual health: the relationship with gender, age, gender-stereotypical beliefs, and perceptions of communication inappropriateness. Sex Roles. 2009;60(9–10):669–81. doi:10.1007/s11199-008-9577-1.
  • Sobecki JN, Curlin FA, Rasinski KA, Lindau ST. What we don’t talk about when we don’t talk about sex: results of a national survey of U.S. obstetrician/gynecologists. J Sex Med. 2012;9(5):1285–94. doi:10.1111/j.1743-6109.2012.02702.x.
  • Lin C, Mullen J, Smith D, Kotarba M, Kaplan SJ, Tu P. Healthcare providers’ vaccine perceptions, hesitancy, and recommendation to patients: a systematic review. Vaccines (Basel). 2021;9(7):713. doi:10.3390/vaccines9070713.
  • Conrey R, Valencia V, Cioletti A, Williams-Brown MY. Regional variation in human papillomavirus vaccination uptake and completion among adolescents 13–17 in the state of Texas. Vaccine. 2020;38(25):4119–24. doi:10.1016/j.vaccine.2020.03.059.
  • Molokwu J, Dwivedi A, Mallawaarachchi I, Hernandez A, Shokar N. Tiempo de vacunarte (time to get vaccinated): outcomes of an intervention to improve HPV vaccination rates in a predominantly Hispanic community. Prev Med. 2019;121:115–20. doi:10.1016/j.ypmed.2019.02.004.
  • Ejezie CL, Osaghae I, Ayieko S, Cuccaro P. Adherence to the recommended HPV vaccine dosing schedule among adolescents aged 13 to 17 years: findings from the national immunization survey-teen, 2019-2020. Vaccines (Basel). 2022;10(4):577. doi:10.3390/vaccines10040577.
  • Texas Association of Community Health Centers. Texas health centers: fact sheet; 2021 [accessed 2022 Apr]. https://tachc.org/common/Uploaded%20files/Policy%20and%20Advocacy/Fact%20Sheets/Fact%20Sheet%202021.pdf
  • Chido-Amajuoyi OG, Talluri R, Wonodi C, Shete S. Trends in HPV vaccination initiation and completion within ages 9-12 years: 2008-2018. Pediatrics (Evanston). 2021;147(6):1. doi:10.1542/peds.2020-012765.